Pomona, CA, United States of America

Avinash Seth

This inventor holds 4 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: Gamot Global Pte. Ltd., Honed Life Sciences, LLC. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Avinash Seth. Retrieved from https://idiyas.com/inventor/avinash-seth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.5

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Avinash Seth: Innovator in Tobacco and Cancer Treatment

Introduction

Avinash Seth is a notable inventor based in Pomona, CA (US), recognized for his contributions to the fields of tobacco products and cancer treatment. He holds a total of 4 patents, showcasing his innovative approach to addressing significant health challenges.

Latest Patents

One of his latest patents focuses on the use of isothiocyanate in smokeless tobacco products. This invention describes methods that utilize a tobacco product to reduce or mitigate some of the negative effects of tobacco consumption, particularly cancer development. The tobacco product contains nicotine, at least one isothiocyanate or isothiocyanate precursor, myrosinase, and a synthetic isothiocyanate. Additionally, the product can include thymoquinone, resveratrol, synthetic vitamin C, or combinations thereof. Another significant patent involves methods of treating cancer using NK cells. This patent provides methods for generating clinically safe NK cells derived from non-fully differentiated stem cells and their application in cancer treatment. The process involves co-culturing non-fully differentiated stem cells with endogenous NK cells isolated from adipocyte-containing tissue, resulting in a high percentage of clinically safe NK cells. The anti-tumor activity of these NK cells in vitro is comparable to that of endogenous NK cells, offering a promising platform for effective adoptive immunotherapy for cancer patients.

Career Highlights

Avinash has worked with several companies, including Honed Life Sciences, LLC and Gamot Global Pte. Ltd. His experience in these organizations has contributed to his innovative work and the development of his patents.

Collaborations

Throughout his career, Avinash has collaborated with notable individuals such as Nikko Lowe and Robert D Fish. These partnerships have likely enhanced his research and development efforts.

Conclusion

Avinash Seth's innovative work in the fields of tobacco products and cancer treatment highlights his commitment to improving health outcomes. His patents reflect a deep understanding of complex biological processes and a dedication to finding solutions to pressing health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…